Compositions comprising an extract of
View Patent ↗The present invention relates to an anoikis-inducing agent comprising a Tiarella polyphylla extract, a tiarellic acid compound isolated therefrom or a pharmaceutically acceptable salt thereof, which is specific to cancer cells expressing a tumor-associated antigen L6 or a homolog thereof. The Tiarella polyphylla extract, the tiarellic acid compound isolated therefrom or pharmaceutically acceptable salt thereof of the present invention leads to loss of cell adhesion to reduce cancer cell proliferation and exhibits the effect of inducing cell death in cancer cells expressing a tumor-associated antigen L6 or a homolog thereof, thereby being used for preventing and treating cancer diseases due to a tumor-associated antigen L6 or a homolog thereof.
1. A method of treating cancer, comprising:
administrating to a patient in need thereof a cancer cell-specific anoikis-inducing agent, thereby treating cancer, wherein the cancer being treated is TM4SF5 expressing cancer which is selected from the group consisting of pancreatic cancer, gastric cancer, colon cancer, carcinoma of papilla vateri, soft tissue sarcoma, nonendocrine lung cancer, ACTH (corticotropin)-negative bronchial carcinoid tumor and liver cancer, and wherein the cancer cell-specific anoikis-inducing agent comprises tiarellic acid, or a pharmaceutically acceptable salt thereof or a Tiarella polyphylla extract comprising the same.
2. The method according to claim 1 , wherein the extract is a crude extract or an extract soluble in a polar solvent.
3. The method according to claim 2 , wherein the crude extract is an extract being soluble in solvent, wherein said solvent comprises purified water, C1-C4 lower alcohol, or the mixtures thereof.
4. The method according to claim 2 , wherein the extract soluble in a polar solvent is an extract being soluble in a solvent selected from the group consisting of water, methanol, ethanol, butanol, and the mixtures thereof.
5. The method according to claim 1 , wherein the tiarellic acid, pharmaceutically acceptable salt thereof or Tiarella polyphylla extract comprising the same is administered in the form of a dietary supplement composition.
6. The method according to claim 5 , wherein the dietary supplement composition is in the form of a tablet, a capsule, a pill, or liquid.